Genmab

E241390

Genmab is a Danish biotechnology company specializing in the development of antibody-based cancer therapies.

All labels observed (2)

Label Occurrences
Genmab canonical 10
Genmab A/S 5

How this entity was disambiguated

Statements (47)

Predicate Object
instanceOf biotechnology company ⓘ
public company ⓘ
collaboratesWith Janssen Biotech ⓘ
Johnson & Johnson ⓘ
Novartis ⓘ
Roche ⓘ
Seagen ⓘ
country Denmark ⓘ
focusesOnDisease cancer ⓘ
hematologic malignancies ⓘ
solid tumors ⓘ
foundedBy Florian Schönharting ⓘ
Jan G. J. van de Winkel ⓘ
hasCEO Jan G. J. van de Winkel ⓘ
hasOfficeLocation Japan ⓘ
New Jersey ⓘ
Princeton ⓘ
The Netherlands ⓘ
linked to: Netherlands

Tokyo ⓘ
United States ⓘ
Utrecht ⓘ
headquartersLocation Copenhagen ⓘ
Denmark ⓘ
inception 1999 ⓘ
industry biotechnology ⓘ
pharmaceuticals ⓘ
ISIN DK0010272202 ⓘ
languageOfWorkOrName Danish ⓘ
English ⓘ
legalForm Aktieselskab ⓘ
listedIn OMX Copenhagen 25 index ⓘ
linked to: OMX Copenhagen 25
product Daratumumab ⓘ
linked to: daratumumab

Ofatumumab ⓘ
Teprotumumab ⓘ
productType therapeutic antibodies ⓘ
researchArea autoimmune diseases ⓘ
immuno-oncology ⓘ
specializesIn antibody-based cancer therapies ⓘ
monoclonal antibodies ⓘ
oncology ⓘ
stockExchange Nasdaq Copenhagen ⓘ
Nasdaq Global Select Market ⓘ
technology antibody engineering ⓘ
antibody-drug conjugates ⓘ
bispecific antibodies ⓘ
tickerSymbol GMAB ⓘ
website https://www.genmab.com ⓘ

How these facts were elicited

Referenced by (15)

Full triples — surface form annotated when it differs from this entity's canonical label.

Darzalex → developedBy → Genmab ⓘ
daratumumab → developedBy → Genmab ⓘ
GMAB → represents → Genmab A/S ⓘ
linked to: Genmab
daratumumab → developedBy → Genmab A/S ⓘ
subject linked to: GMAB
linked to: Genmab
GMAB → underlyingCompany → Genmab A/S ⓘ
linked to: Genmab
Ofatumumab → developer → Genmab ⓘ
Seagen → collaboratesWith → Genmab ⓘ
DK0010272202 → identifiesIssuer → Genmab A/S ⓘ
linked to: Genmab
DK0010272202 → issuerName → Genmab A/S ⓘ
linked to: Genmab